MindMed Announces Positive Results from Collaborators' Placebo-Controlled Investigator-Initiated Trial Published in Peer-Reviewed JournalPRNewsWire • 09/08/22
Wall Street Analysts Predict a 399% Upside in Mind Medicine MindMed Inc. (MNMD): Here's What You Should KnowZacks Investment Research • 08/30/22
MindMed Announces First Patient Dosed in Phase 2b Trial of MM-120 in Generalized Anxiety DisorderPRNewsWire • 08/25/22
Bed, Bath (BBBY) Shareholders Buffeted by Large Meme Player Sales, MindMed (MNMD) Now in Their Sight24/7 Wall Street • 08/19/22